Day One Biopharmaceuticals, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
DAWN on Nasdaq
Industry
Pharmaceutical Preparations
Location
2000 Sierra Point Parkway, Suite 501, Brisbane, CA

Insiders trading volume in the past year

Day One Biopharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
AI Day1 LLC 10%+ Owner $163M +$12M +7.94% Aug 1, 2024
Canaan XI L.P. 10%+ Owner $81.4M Sep 21, 2022
Takeda Pharmaceutical Co Ltd 10%+ Owner $71.5M Dec 7, 2021
Atlas Venture Fund XI, L.P. 10%+ Owner $70.2M Dec 12, 2022
Samuel C. Blackman Head Of R&D $36.1M -$2.51M -6.5% Oct 31, 2024
Atlas Venture Opportunity Fund II, L.P. 10%+ Owner $20.6M Jun 17, 2022
Jeremy Bender CHIEF EXECUTIVE OFFICER, Director $17.4M -$1.84M -9.56% Aug 15, 2024
Atlas Venture Opportunity Fund I, L.P. 10%+ Owner $9.27M Jul 1, 2022
Charles N. York II Coo, Cfo And Secretary $5.95M -$1.21M -16.9% Aug 15, 2024
Julie Papanek Grant Director $3.86M Mar 1, 2023
Adam Dubow General Counsel $1.89M -$209K -9.93% Aug 15, 2024
Saira Ramasastry Director $534K -$132K -19.8% Jun 21, 2024
John A. Josey Director May 23, 2024
William Grossman Director May 23, 2024
Natalie C. Holles Director May 23, 2024
J. Scott Garland Director May 23, 2024
Garry A. Nicholson Director May 23, 2024
Daniel J. Becker Director Jun 22, 2023
Michael Gladstone Director May 23, 2024
Habib J. Dable Director May 23, 2024

Recent Insider Transactions by Companies or Individuals for Day One Biopharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.